Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
Clinical trial NCT00398489 · UNKNOWN
Trial details
- NCT number
- NCT00398489
- Sponsor
- Technical University of Munich
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-10-01
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.